IRA 2020 Conference

Sponsorship Opportunities Available: Platinum, Gold, Silver and Additional Levels
Conference Venue

Co-Founder, President and CSO, Pandion Therapeutics

Jo has an incredible track record in the inflammation drug development industry and is, of course, known to many in our organization. Her successful leadership at Pandion Therapeutics has lead to its recognition as a FireceBiotech “Fierce 15” company in 2018 and her board appointments at Quench, HotSpot, Finch etc. are testament to how highly she is regarded in this space. Indeed only yesterday Pandion announced its first subject dosed in a Phase 1 Clinical Trial of PT101, an IL-2 Mutein Fc Fusion Therapy for Autoimmune Disease. Moreover, Jo’s well-admired leadership at world class organizations (Immunex, Amgen, Biogen) coupled with her inspirational advocacy for women in leadership and STEM, make her one of the most compelling leaders in the inflammation space. We are thrilled that she will share her expertise and experience at IRA2020 and thus ensure that IRA2020 gets off to a terrific start.

Preliminary Scientific Program

  • Emerging Strategies in the Discovery of Inflammation Therapy
  • Translational Research and Innovative Technologies
  • New Frontiers in Systems Immunology: How new technologies and AI can guide therapeutics discovery
    and development
  • New Approaches in Controlling IBD by Targeting the Epithelial Barrier
  • Microbial-host Interactions – Early Discovery
  • Immune Boosting as a Broad-spectrum Antiviral Approach
  • Emerging Therapeutic Strategies in Inflammation: New Drugs and Novel Approaches
  • Networking/Meet the Professor and Professional
  • Patient Perspectives in Atopic Dermatitis
  • Selected Presentations from Award-winning Posters

Additional Events

  • Scientific Poster Sessions
  • Exhibits
  • Lunch and Learns
  • Networking and Mentoring
  • 50th Anniversary Banquet
  • Social Program